FDA bans controversial Red Dye No. 3 from foods and medicine
The FDA is banning the artificial coloring Red Dye No. 3 from food, medicine and supplements. It is used in thousands of ...
The Pharmaceutical Industry in Germany: A Powerhouse of Innovation, Research, and Global Influence
Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...
kffhealthnews3d
Truveta Says It Will Create Huge Archive Of Patients’ Genetic Data
The health data company, based in Bellevue, Washington, plans to collect leftover specimens from consenting patients who get routine health care at participating facilities, Stat reported. Also in the ...
BlueRock accelerates Parkinson’s disease therapy to Phase III
The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...
pharmaphorum3d
Bayer gains ground in two-fronted Parkinson's offensive
Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...
FierceBiotech4d
JPM25: Bayer moves allogeneic cell therapy into phase 3 Parkinson's trial
Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...
Managed Healthcare Executive6d
Bayer Submits Supplemental NDA for Kerendia in Heart Failure
Kerenida is currently approved to slow the progression chronic kidney disease associated with type 2 diabetes.
ncbiotech.org6d
Piedmont Triad Regenerative Medicine Engine awards $2.5 million in grants to area companies
The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has awarded six regional companies $2.5 million in grants as part of its inaugural Ecosystem ...